Products

  A recent trend in drug development is to create new drugs that target a specific molecule identified by means of a genomic approach. Nevertheless, many drugs fail to reach clinical application, and costs associated with such unsuccessful drugs are high. One of the major reasons for drop-out is inappropriate ADME (absorption, distribution, metabolism, and excretion) properties of candidates, resulting in low bioavailability or toxicity. It is, therefore, important to predict such problems at as early a stage as possible in the development process. GenoMembrane provides transporter reagents and research services for this purpose.

  GenoMembrane provides ABC Transporter Membranes and Vesicles as research reagents, and functional screening, gene profiling or polymorphism analysis are also available as research services.

GenoMembrane's Services